Article
Modern management of juvenile myoclonic epilepsy.
Expert review of neurotherapeutics - 1 Jun 2016
Brodie Martin J
Abstract excerpt
Juvenile myoclonic epilepsy (JME) is a common genetic epilepsy syndrome usually presenting in adolescence and characterized by myoclonic jerks, predominately in the arms, associated with tonic-clonic seizures and less often generalized absences. Although the evidence base for treating JME is weak, most experts regard sodium valproate as drug of first choice. The recent diktat from the European regulatory agency -...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
